Among those with cytoplasmic-positive CRC, the rate of strongly positive nuclear HMGB1 expression was 60.2% (56/93), which was significantly lower than that in the cytoplasmic-negative CRC cohort (92.0%, 254/276) (P < 0.01, Table 3). The gene discussed is HMGB1; the disease is colorectal carcinoma.